Goldman Sachs initiates coverage on Cepheid (NASDAQ: CPHD) with a Buy rating and $30 price target, suggesting 18% upside.

This article: 110 words
-->

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE